Therapy insight: The effect of tight glycemic control in acute illness

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 3, 2007, Pages 270-278

  Langouche, Lies ^b   Vanhorebeek, Ilse ^b   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

Critical illness; Hyperglycemia; Hypoglycemia; Insulin; Organ failure

Indexed keywords

GLUCOSE; INSULIN;

ACUTE DISEASE; CRITICALLY ILL PATIENT; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE UNIT; MORBIDITY; PRIORITY JOURNAL; REVIEW; RISK; SURVIVAL;

ACUTE DISEASE; ANIMALS; BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTENSIVE CARE;

EID: 33847190721     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0426     Document Type: Review

References (63)

1. Van den Berghe G et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367
2. Rovlias A and Kotsou S (2000) The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46: 335-342
3. Yendamuri S et al. (2003) Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55: 33-38
4. Bochicchio GV et al. (2005) Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 58: 921-924
5. Capes SE et al. (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355: 773-778
6. Capes SE et al. (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32: 2426-2432
7. Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78: 1471-1478
8. Van den Berghe G et al. (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64: 1348-1353
9. Ingels C et al. (2006) Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 27: 2716-2724
10. Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79: 992-1000
11. Grey NJ and Perdrizet GA (2004) Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 10 (Suppl 2): S46-S52
12. Van den Berghe G et al. (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461
13. Van den Berghe G et al. (2006) Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55: 3151-3159
14. Van den Berghe G et al. (2006) Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34: 612-616
15. Krinsley JS and Jones RL (2006) Cost analysis of intensive glycemic control in critically ill adult patients. Chest 129: 644-650
16. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
17. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
18. Vriesendorp TM et al. (2006) Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34: 96-101
19. Vriesendorp TM et al. (2006) Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34: 2714-2718
20. Watt MJ et al. (2001) Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J Physiol 534: 269-278
21. Wolfe RR (1979) Glucose metabolism in severely burned patients. Metabolism 28: 1031-1039
22. Wolfe RR et al. (1987) Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317: 403-408
23. Stephens JM et al. (1992) Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochem Biophys Res Commun 183: 417-422
24. Virkamaki A and Yki-Jarvinen H (1994) Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134: 2072-2078
25. McCowen KC et al. (2001) Stress-induced hyperglycemia. Crit Care Clin 17: 107-124
26. Meszaros K et al. (1987) Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem 262: 10965-10970
27. Van den Berghe G et al. (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31: 359-366
28. Finney SJ et al. (2003) Glucose control and mortality in critically ill patients. JAMA 290: 2041-2047
29. Mesotten D et al. (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89: 219-226
30. Mesotten D et al. (2002) Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab 87: 5516-5523
31. Klip A et al. (1994) Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 8: 43-53
32. Van den Berghe G (2004) How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114: 1187-1195
33. Gosmanov AR et al. (2006) De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose. Am J Physiol Endocrinol Metab 290: E516-E522
34. Pekala P et al. (1990) Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-α, but not by insulin. J Biol Chem 265: 18051-18054
35. Shikhman AR et al. (2001) Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 167: 7001-7008
36. Quinn LA and McCumbee WD (1998) Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 177: 94-102
37. Clerici C and Matthay MA (2000) Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 88: 1890-1896
38. Sanchez-Alvarez R et al. (2004) Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J Neurochem 89: 703-714
39. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820
40. Giugliano D et al. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267
41. West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17: 171-180
42. Aulak KS et al. (2004) Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol 286: H30-H38
43. Vanhorebeek I et al. (2005) Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365: 53-59
44. Hansen TK et al. (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88: 1082-1088
45. Weekers F et al. (2003) Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144: 5329-5338
46. Ellger B et al. (2006) Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55: 1096-1105
47. Jeschke MG et al. (2004) Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239: 553-560
48. Black CT et al. (1990) Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 30: 830-832
49. Nielson CP and Hindson DA (1989) Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38: 1031-1035
50. Perner A et al. (2003) High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 29: 642-645
51. Lanza-Jacoby S et al. (1992) Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochim Biophys Acta 1124: 233-240
52. Khovidhunkit W et al. (2000) Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181 (Suppl 3): S462-S472
53. Carpentier YA and Scruel O (2002) Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5: 153-158
54. Harris HW et al. (1990) Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86: 696-702
55. Langouche L et al. (2005) Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115: 2277-2286
56. Siroen MP et al. (2005) Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33: 504-510
57. Das UN (2003) Insulin: an endogenous cardioprotector. Curr Opin Crit Care 9: 375-383
58. Mehta SR et al. (2005) Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293: 437-446
59. Malmberg K et al. (2005) Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26: 650-661
60. Gao F et al. (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497-1502
61. Jonassen AK et al. (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89: 1191-1198
62. Bothe W et al. (2004) Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg 78: 1650-1657
63. Vanhorebeek I et al. (2006) Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 91: 3803-3813